Iron protein succinylate oral solution — Competitive Intelligence Brief

Iron protein succinylate oral solution (Iron protein succinylate oral solution) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Iron supplement. Area: Hematology.

marketed Iron supplement Hematology Small molecule

Target snapshot

Iron protein succinylate oral solution (Iron protein succinylate oral solution) — Lee's Pharmaceutical Limited. Iron protein succinylate provides bioavailable iron in a protein-chelated form to treat iron deficiency by replenishing iron stores.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Iron protein succinylate oral solution TARGET	Iron protein succinylate oral solution	Lee's Pharmaceutical Limited	marketed	Iron supplement
F (ferrous sulphate)	F (ferrous sulphate)	Abdelwahed, Mai Mahmoud Mohamed, M.D.	marketed	Iron supplement	Iron (Fe2+) for hemoglobin and myoglobin synthesis
Erythropoietin subcutaneously and Iron intravenously	Erythropoietin subcutaneously and Iron intravenously	Catharina Ziekenhuis Eindhoven	marketed	Erythropoiesis-stimulating agent combined with iron supplement	Erythropoietin receptor (EPOR); iron as cofactor for hemoglobin synthesis
Ferrous sulphate	Ferrous sulphate	University of Lausanne	marketed	Iron supplement	Iron (Fe2+) for hemoglobin and myoglobin synthesis
Sucrosomial Iron	Sucrosomial Iron	Cardiochirurgia E.H.	marketed	Iron supplement
Daily Ferrous Sulfate	Daily Ferrous Sulfate	Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri	marketed	Iron supplement
FerroGrad by Abbott	FerroGrad by Abbott	Clinica Fabia Mater	marketed	Iron supplement

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Iron supplement class)

1. Tanabe Pharma Corporation · 4 drugs in this class
2. Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri · 2 drugs in this class
3. Universidade Federal Fluminense · 2 drugs in this class
4. Clinica Fabia Mater · 1 drug in this class
5. GlaxoSmithKline · 1 drug in this class
6. Hatem AbuHashim · 1 drug in this class
7. Hospital Universitari Vall d'Hebron Research Institute · 1 drug in this class
8. Laboratoire Innotech International · 1 drug in this class
9. Lee's Pharmaceutical Limited · 1 drug in this class
10. Milton S. Hershey Medical Center · 1 drug in this class